Strzelecki, D.; Podgórski, M.; Kałużyńska, O.; Stefańczyk, L.; Kotlicka-Antczak, M.; Gmitrowicz, A.; Grzelak, P.
Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex. Int. J. Mol. Sci. 2015, 16, 24475-24489.
https://doi.org/10.3390/ijms161024475
AMA Style
Strzelecki D, Podgórski M, Kałużyńska O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A, Grzelak P.
Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex. International Journal of Molecular Sciences. 2015; 16(10):24475-24489.
https://doi.org/10.3390/ijms161024475
Chicago/Turabian Style
Strzelecki, Dominik, Michał Podgórski, Olga Kałużyńska, Ludomir Stefańczyk, Magdalena Kotlicka-Antczak, Agnieszka Gmitrowicz, and Piotr Grzelak.
2015. "Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex" International Journal of Molecular Sciences 16, no. 10: 24475-24489.
https://doi.org/10.3390/ijms161024475
APA Style
Strzelecki, D., Podgórski, M., Kałużyńska, O., Stefańczyk, L., Kotlicka-Antczak, M., Gmitrowicz, A., & Grzelak, P.
(2015). Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex. International Journal of Molecular Sciences, 16(10), 24475-24489.
https://doi.org/10.3390/ijms161024475
